A new study reveals that ensifentrine, a novel COPD treatment, significantly reduces COPD-related healthcare usage over 48 ...

Discover the latest insights from the TOReTO study on COPD management: Dual bronchodilator therapy has been shown to reduce exacerbations, with varying efficacy between current and former smokers.

Diwali is synonymous with fireworks but such celebrations contribute to air pollution by releasing particulate matter (PM10 ...

Ohtuvayre™ (ensifentrine) is the Company’s first commercial product and the first inhaled therapy for the maintenance treatment of COPD that combines bronchodilator and non-steroidal anti ...

Q3 2024 Earnings Conference Call November 4, 2024 9:00 AM ETCompany ParticipantsDavid Zaccardelli - President and ...

After Diwali celebrations, the air quality in Gurgaon has significantly deteriorated, leading to a sharp rise in respiratory ...

Discontinuing medical treatment can trigger asthma attacks, so regular check-ups are essential for managing the condition.

If advised by a healthcare provider, bronchodilators, which help in keeping the airways open, can make breathing easier ...

As reported by the Central Pollution Control Board's SAMEER app, Mumbai's Air Quality Index (AQI) on Sunday was 157, which ...

Ohtuvayre™ (ensifentrine) launch recorded Q3 net sales of $5.6 million and October net sales exceeded Q3Through October more than 2,200 unique ...

It’s something Lindsay Bishop is seeing more and more of in her role as COPD educator for Open Airways. COPD is a chronic lung condition characterised by swollen, inflamed airways and excessive ...

LONDON and RALEIGH, N.C., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a biopharmaceutical company focused on respiratory diseases, announces ...